Preview

South Russian Journal of Therapeutic Practice

Advanced search

Palliative status of patients with chronic heart failure: relationship with body composition parameters, clinical and laboratory parameters

https://doi.org/10.21886/2712-8156-2024-5-4-39-46

Abstract

Objective: to determine the relationship between parameters body composition, clinical status, laboratory parameters and severity of painful symptoms in patients with chronic heart failure.

Materials and methods: the study involved 298 patients with CHF. The body composition was assessed: the presence of sarcopenia and obesity (with the calculation of the muscle mass index IMM/BMI), functional class, left ventricular ejection fraction, markers galectin-3, hsСRP, Na-proBNP, Bartel index. A 10-point Edmont scale was used to assess the severity of painful symptoms. A factor analysis was performed, as well as a Pearson correlation analysis.

Results: the study revealed 5 components: A factor of adequacy of muscle functions, a factor of systolic dysfunction, a factor of impaired functional status, a factor of functional activity, and an age factor. The conducted correlation analysis showed the presence of links between the components and the severity of painful symptoms of moderate and mild severity.

Conclusion: the body composition of patients is associated with the severity of painful symptoms in patients with CHF who need palliative care. It is necessary to take into account body composition when developing algorithms for managing patients with CHF at the stage of palliative care.

About the Authors

V. I. Shevtsova
N.N. Burdenko Voronezh State Medical University
Russian Federation

Veronika I. Shevtsova, Cand. Sci. (Med.), Associate Professor of the Department of infectious diseases and clinical immunology

Voronezh



A. A. Pashkova
N.N. Burdenko Voronezh State Medical University

Anna A. Pashkova, Dr. Sci. (Med.), Professor, Head of the Department of Polyclinic Therapy

Voronezh



O. N. Krasnoruckaya
N.N. Burdenko Voronezh State Medical University

Olga N. Krasnoruckaya, Dr. Sci. (Med.),  Professor of the Department of infectious diseases and clinical immunology

Voronezh



References

1. Bojcov S.A. Chronic heart failure: the evolution of etiology, prevalence and mortality over the past 20 years. Terapevticheskij arhiv. 2022; 94 (1): 5-8. (In Russ.) DOI: 10.26442/00403660.2022.01.201317

2. Fomin I.V. Chronic heart failure in the Russian Federation: what do we know today and what should we do. Rossijskij Kardiologicheskij Zhurnal. 2016;8:7-13. (In Russ.) DOI: 10.15829/1560-4071-2016-8-7-13

3. Vinogradova N.G., Polyakov D.S., Fomin I.V. Analysis of mortality in patients with CHF after decompensation with long-term follow-up in specialized medical care and in real clinical practice. Kardiologiya. 2020;60(4):91–100. (In Russ.) DOI:10.18087/cardio.2020.4.n1014

4. Larina V. N., Chukaeva I. I., Larin V. G. Current Trends and Possibilities of Providing Medical Palliative Care in Chronic Heart Failure. Kardiologiia. 2019;59(1):84–92. (in Russ.) DOI:10.18087/cardio.2019.1.10219

5. Rashid M.A., Novikov G.A., Vajsman M.A., Largina M.O., Podkopaev D.V. Palliative care for chronic heart failure: relevance, tasks and problems. Palliative medicine and rehabilitation. 2022;3:14-24. (In Russ.) eLIBRARY ID: 49539108 EDN: DWYYYT

6. Drapkina O.M., Skripnikova I.A., Yaralieva E.K., et al. Body composition in patients with heart failure. Cardiovascular Therapy and Prevention. 2022;21(12):3451. (In Russ.) DOI: 10.15829/1728-8800-2022-3451

7. Zuo X, Li X, Tang K, Zhao R, Wu M, Wang Y, Li T. Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(3):1183-1198. DOI: 10.1002/jcsm.13221

8. Jeng C, et al. Race and socioeconomic effect on sarcopenia and sarcopenic obesity in the Louisiana Osteoporosis Study (LOS). JCSM Clin Rep. 2018;3(2):1-8. DOI: 10.17987/jcsm-cr.v3i2.27

9. Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P, Xu J, Zhao Z. Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021;8(2):1007-1017. DOI: 10.1002/ehf2.13255

10. Saito H, Matsue Y, Kamiya K, Kagiyama N, Maeda D, Endo Y, et al. Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF. BMC Geriatr. 2022;22(1):556. DOI: 10.1186/s12877-022-03168-3

11. Berns S. A., Sheptulina A. F., Mamutova E. M., Kiselev A. R., Drapkina O. M. Sarcopenic obesity: epidemiology, pathogenesisand diagnostic criteria. Cardiovascular Therapy and Prevention.2023;22(6):3576. (in Russ.) DOI: 10.15829/1728-8800-2023-3576

12. Boytsov S.A., Drapkina O.M., Shlyakhto E.V., Konradi A.O., Balanova Yu.A., Zhernakova Yu.V., et al. Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later. Cardiovascular Therapy and Prevention. 2021;20(5):3007. (In Russ.) DOI: 10.15829/1728-8800-2021-3007

13. Grigorieva I.I., Raskina T.A., Letaeva M.V., Malyshenko O.S., Averkieva Yu.V., Masenko V.L., et al. Sarcopenia: pathogenesis and diagnosis. Fundamental and Clinical Medicine. 2019;4(4):105-116. (In Russ.) DOI: 10.23946/2500-0764-2019-4-4-105-116

14. Podzolkov VI, Dragomiretsksya NA, Kazadaeva AV, Beliaev YuG, Tolmacheva AV. Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3. Rossijskij kardiologicheskij zhurnal. 2022; 27(4): 73-78. (In Russ.) DOI: 10.15829/1560-4071-2022-4957.

15. Gulyaev N.I., Adamov A.A., Ahmetshin I.M. The effect of sarcopenia on the course and prognosis in patients with chronic heart failure. Mediko-farmacevticheskij zhurnal «Pul's»,25 (2), 124-133. (In Russ.) DOI: 10.26787/nydha-2686-6838-2023-25-2-124-133

16. Konishi M, Kagiyama N, Kamiya K, Saito H, Saito K, Ogasahara Y, et al. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction. Eur J Prev Cardiol. 2021;28(9):1022-1029. DOI: 10.1093/eurjpc/zwaa117

17. de Boer RA, Lok DJ, Jaarsma T, van der Meer P, Voors AA, Hillege HL, et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med. 2011;43(1):60-68. DOI: 10.3109/07853890.2010.538080

18. Skripnikova I.A., Yaralieva E.K., Myasnikov R.P., Kulikova O.V., Novikov V.E., Kosmatova O.V., et al. Body composition and functional activity in men with heart failure. Rational Pharmacotherapy in Cardiology. 2023;19(6):557-564. (In Russ.) DOI: 10.20996/1819-6446-2023-2975

19. Konishi M, Akiyama E, Matsuzawa Y, Sato R, Kikuchi S, Nakahashi H, et al. Prognostic impact of upper and lower extremity muscle mass in heart failure. ESC Heart Fail. 2023;10(1):732-737. DOI: 10.1002/ehf2.14195

20. Fuentes-Abolafio IJ, Stubbs B, Pérez-Belmonte LM, Bernal-López MR, Gómez-Huelgas R, Cuesta-Vargas AI. Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2020;20(1):512. DOI: 10.1186/s12872-020-01725-5


Review

For citations:


Shevtsova V.I., Pashkova A.A., Krasnoruckaya O.N. Palliative status of patients with chronic heart failure: relationship with body composition parameters, clinical and laboratory parameters. South Russian Journal of Therapeutic Practice. 2024;5(4):39-46. (In Russ.) https://doi.org/10.21886/2712-8156-2024-5-4-39-46

Views: 292


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2712-8156 (Print)